Anthony B. Evnin, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 112,451 shares at $13.56 ($1.5M) on 2014-09-30, disclosed to the SEC on 2014-10-02.
Open-market sale of $1.5M INFI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | BUY | 2018-11-26 | $223 | — | Filing → |
| AVEO | SELL | 2018-11-16 | $4.3M | — | Filing → |